KR940000829B1 - 항정신병성 융합-환의 피리디닐 피페라진 유도체의 제조방법 - Google Patents

항정신병성 융합-환의 피리디닐 피페라진 유도체의 제조방법 Download PDF

Info

Publication number
KR940000829B1
KR940000829B1 KR1019860003445A KR860003445A KR940000829B1 KR 940000829 B1 KR940000829 B1 KR 940000829B1 KR 1019860003445 A KR1019860003445 A KR 1019860003445A KR 860003445 A KR860003445 A KR 860003445A KR 940000829 B1 KR940000829 B1 KR 940000829B1
Authority
KR
South Korea
Prior art keywords
compound
hydrogen
formula
lower alkyl
preparing
Prior art date
Application number
KR1019860003445A
Other languages
English (en)
Korean (ko)
Other versions
KR860009008A (ko
Inventor
스트워트 뉴 제임스
피. 예비취 죠셉
Original Assignee
브리스톨-마이어즈 스퀴브 캄파니
이삭 쟈코브스키
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브리스톨-마이어즈 스퀴브 캄파니, 이삭 쟈코브스키 filed Critical 브리스톨-마이어즈 스퀴브 캄파니
Publication of KR860009008A publication Critical patent/KR860009008A/ko
Application granted granted Critical
Publication of KR940000829B1 publication Critical patent/KR940000829B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019860003445A 1985-05-06 1986-05-02 항정신병성 융합-환의 피리디닐 피페라진 유도체의 제조방법 KR940000829B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73120185A 1985-05-06 1985-05-06
US731,201 1985-05-06

Publications (2)

Publication Number Publication Date
KR860009008A KR860009008A (ko) 1986-12-19
KR940000829B1 true KR940000829B1 (ko) 1994-02-02

Family

ID=24938510

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860003445A KR940000829B1 (ko) 1985-05-06 1986-05-02 항정신병성 융합-환의 피리디닐 피페라진 유도체의 제조방법

Country Status (25)

Country Link
JP (1) JPH0753728B2 (es)
KR (1) KR940000829B1 (es)
CN (1) CN1017901B (es)
AT (1) AT398572B (es)
AU (1) AU593244B2 (es)
BE (1) BE904724A (es)
CA (1) CA1278792C (es)
CH (1) CH672787A5 (es)
DE (1) DE3615180C2 (es)
DK (1) DK165745C (es)
EG (1) EG18206A (es)
ES (6) ES8801250A1 (es)
FI (1) FI85484C (es)
FR (1) FR2581385B1 (es)
GB (1) GB2174703B (es)
GR (1) GR861149B (es)
HU (1) HU195509B (es)
IE (1) IE59201B1 (es)
IT (1) IT1208607B (es)
LU (1) LU86421A1 (es)
MY (1) MY100777A (es)
NL (1) NL8601146A (es)
PT (1) PT82523B (es)
SE (1) SE465270B (es)
ZA (1) ZA862046B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
IE903410A1 (en) * 1989-10-09 1991-04-10 Novo Nordisk As Indole derivatives, their preparation and use
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
FR2738822B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
FR2738824B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1 -yl)alkyl)-3,4-dihydroquinazolin-2(1h)-one,leur preparation et leur application en therapeutique
JP3335362B2 (ja) * 1995-09-15 2002-10-15 サノフィ―サンテラボ キノレイン−2(1h)−オン誘導体セロトニンアンタゴニスト
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Also Published As

Publication number Publication date
GB2174703B (en) 1988-10-26
AU593244B2 (en) 1990-02-08
HU195509B (en) 1988-05-30
FI85484B (fi) 1992-01-15
DK165745C (da) 1993-06-14
DE3615180C2 (de) 1996-03-07
JPH0753728B2 (ja) 1995-06-07
HUT43848A (en) 1987-12-28
GR861149B (en) 1986-09-09
IT1208607B (it) 1989-07-10
NL8601146A (nl) 1986-12-01
ES8900253A1 (es) 1989-05-16
ATA121486A (de) 1994-05-15
SE8602061D0 (sv) 1986-05-05
GB2174703A (en) 1986-11-12
ES8801250A1 (es) 1987-12-16
AU5679586A (en) 1986-11-13
LU86421A1 (fr) 1986-12-05
FI85484C (fi) 1992-04-27
ES554659A0 (es) 1987-12-16
FR2581385A1 (fr) 1986-11-07
CN86103071A (zh) 1987-03-18
GB8610810D0 (en) 1986-06-11
ES9000005A1 (es) 1989-11-01
ES557809A0 (es) 1988-09-01
ES557855A0 (es) 1989-05-16
PT82523A (en) 1986-06-01
ES8802149A1 (es) 1988-04-01
ZA862046B (en) 1986-11-26
SE465270B (sv) 1991-08-19
ES557757A0 (es) 1988-04-01
IE59201B1 (en) 1994-01-26
ES8900138A1 (es) 1989-01-16
ES557839A0 (es) 1989-01-16
FI861820A0 (fi) 1986-04-30
DK207186D0 (da) 1986-05-05
IE861193L (en) 1986-11-06
AT398572B (de) 1994-12-27
BE904724A (fr) 1986-11-05
MY100777A (en) 1991-02-14
SE8602061L (sv) 1986-11-07
FI861820A (fi) 1986-11-07
CH672787A5 (es) 1989-12-29
DK165745B (da) 1993-01-11
JPS61268681A (ja) 1986-11-28
DE3615180A1 (de) 1986-11-06
CN1017901B (zh) 1992-08-19
EG18206A (en) 1992-09-30
PT82523B (pt) 1988-10-14
ES8802614A1 (es) 1988-09-01
KR860009008A (ko) 1986-12-19
CA1278792C (en) 1991-01-08
FR2581385B1 (fr) 1991-10-04
DK207186A (da) 1986-11-07
IT8620313A0 (it) 1986-05-06

Similar Documents

Publication Publication Date Title
CA1285564C (en) 1-heteroaryl-4-¬(2,5-pyrrolidinedion-1-yl)alkyl|piperazine derivatives
US5001130A (en) Psychotropic heterobicycloalkylpiperazine derivatives
KR910002583B1 (ko) 피페라진 유도체 또는 이의 염, 이의 제조방법 및 활성 성분으로서 이를 함유하는 약제학적 조성물
HU190997B (en) Process for preparing benzisothiazolyl-and benzisoxazolyl-piperazine derivatives
KR940000829B1 (ko) 항정신병성 융합-환의 피리디닐 피페라진 유도체의 제조방법
KR20130046436A (ko) 안드로겐 수용체 길항제, 항암제로서 사이클릭 n,n''-다이아릴티오우레아 및 n,n''-다이아릴우레아, 이의 제조방법 및 이의 용도
HU190827B (en) Process for preparing 2-/4/-/4,4-dialkyl-1,2,6-piperidindion-1-yl/-butyl/-1-piperazinyl/-pyridines
CA1272197A (en) Piperazinoisothiazolones with psychotropic activity
US4880930A (en) Psychotropic acyclic amide derivatives
US4677104A (en) Antipsychotic fused-ring pyridinylpiperazine derivatives
KR900000366B1 (ko) 2-(4-부틸피페라진-1-일)피리딘의 항 정신질환성 환상 이미드 유도체 및 그의 제조방법
US4757073A (en) Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use
KR20010022658A (ko) 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도
JP2571903B2 (ja) 新規アミノアルキルクロモン、その製造方法及びそれを含む薬学的組成物
JPH05247052A (ja) N−アルキルグルタールイミドの4−(4−ピペリジニル)−チエノ〔3,2−c〕ピリジン誘導体
US5116970A (en) Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
JP2021104931A (ja) 含窒素複素環を有するジベンゾアゼピン誘導体
US5206365A (en) Psychotropic heterobicycloalkylpiperazine derivatives
JPH0357903B2 (es)
JPH05345764A (ja) 新規アゼピン誘導体、その製造法およびその用途

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050121

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee